|
1
|
Bast RC Jr, Hennessy B and Mills GB: The
biology of ovarian cancer: New opportunities for translation. Nat
Rev Cancer. 9:415–428. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Phongsavan K, Phengsavanh A, Wahlström R
and Marions L: Women's perception of cervical cancer and its
prevention in rural Laos. Int J Gynecol Cancer. 20:821–826. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Agarwal SM, Raghav D, Singh H and Raghava
GP: CCDB: A curated database of genes involved in cervix cancer.
Nucleic Acids Res. 39(Database): D975–D979. 2011. View Article : Google Scholar :
|
|
4
|
Kawase R, Ishiwata T, Matsuda Y, Onda M,
Kudo M, Takeshita T and Naito Z: Expression of fibroblast growth
factor receptor 2 IIIc in human uterine cervical intraepithelial
neoplasia and cervical cancer. Int J Oncol. 36:331–340.
2010.PubMed/NCBI
|
|
5
|
World Health Organization: International
Agency for Research on Cancer Cervical Cancer - Estimated
Incidence. (Mortality and Prevalence Worldwide in 2012)
|
|
6
|
Pollier J and Goossens A: Oleanolic acid.
Phytochemistry. 77:10–15. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yang EJ, Lee W, Ku SK, Song KS and Bae JS:
Anti-inflammatory activities of oleanolic acid on HMGB1 activated
HUVECs. Food Chem Toxicol. 50:1288–1294. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Reisman SA, Aleksunes LM and Klaassen CD:
Oleanolic acid activates Nrf2 and protects from acetaminophen
hepatotoxicity via Nrf2-dependent and Nrf2-independent processes.
Biochem Pharmacol. 77:1273–1282. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hsu HY, Yang JJ and Lin CC: Effects of
oleanolic acid and ursolic acid on inhibiting tumor growth and
enhancing the recovery of hematopoietic system postirradiation in
mice. Cancer Lett. 111:7–13. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yamai H, Sawada N, Yoshida T, Seike J,
Takizawa H, Kenzaki K, Miyoshi T, Kondo K, Bando Y, Ohnishi Y, et
al: Triterpenes augment the inhibitory effects of anticancer drugs
on growth of human esophageal carcinoma cells in vitro and suppress
experimental metastasis in vivo. Int J Cancer. 125:952–960. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ngo SN, Williams DB and Head RJ: Rosemary
and cancer prevention: Preclinical perspectives. Crit Rev Food Sci
Nutr. 51:946–954. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Shishodia S, Majumdar S, Banerjee S and
Aggarwal BB: Ursolic acid inhibits nuclear factor-kappaB activation
induced by carcinogenic agents through suppression of IkappaBalpha
kinase and p65 phosphorylation: Correlation with down-regulation of
cyclooxygenase 2, matrix metalloproteinase 9, and cyclin D1. Cancer
Res. 63:4375–4383. 2003.PubMed/NCBI
|
|
13
|
Wang X, Zhang F, Yang L, Mei Y, Long H,
Zhang X, Zhang J, Qimuge-Suyila and Su X: Ursolic acid inhibits
proliferation and induces apoptosis of cancer cells in vitro and in
vivo. J Biomed Biotechnol. 2011:4193432011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lin CC, Huang CY, Mong MC, Chan CY and Yin
MC: Antiangiogenic potential of three triterpenic acids in human
liver cancer cells. J Agric Food Chem. 59:755–762. 2011. View Article : Google Scholar
|
|
15
|
Huang CY, Lin CY, Tsai CW and Yin MC:
Inhibition of cell proliferation, invasion and migration by ursolic
acid in human lung cancer cell lines. Toxicol In Vitro.
25:1274–1280. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kim KH, Seo HS, Choi HS, Choi I, Shin YC
and Ko SG: Induction of apoptotic cell death by ursolic acid
through mitochondrial death pathway and extrinsic death receptor
pathway in MDA-MB-231 cells. Arch Pharm Res. 34:1363–1372. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gong YY, Liu YY, Yu S, Zhu XN, Cao XP and
Xiao HP: Ursolic acid suppresses growth and adrenocorticotrophic
hormone secretion in AtT20 cells as a potential agent targeting
adrenocorticotrophic hormone-producing pituitary adenoma. Mol Med
Rep. 9:2533–2539. 2014.PubMed/NCBI
|
|
18
|
Wang X, Wang Y, Chen ZG and Shin DM:
Advances of cancer therapy by nanotechnology. Cancer Res Treat.
41:1–11. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kreuter J: Nanoparticles - a historical
perspective. Int J Pharm. 331:1–10. 2007. View Article : Google Scholar
|
|
20
|
Byrne JD, Betancourt T and Brannon-Peppas
L: Active targeting schemes for nanoparticle systems in cancer
therapeutics. Adv Drug Deliv Rev. 60:1615–1626. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Cho K, Wang X, Nie S, Chen ZG and Shin DM:
Therapeutic nanoparticles for drug delivery in cancer. Clin Cancer
Res. 14:1310–1316. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Iyer AK, Khaled G, Fang J and Maeda H:
Exploiting the enhanced permeability and retention effect for tumor
targeting. Drug Discov Today. 11:812–818. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Talekar M, Kendall J, Denny W and Garg S:
Targeting of nanoparticles in cancer: Drug delivery and
diagnostics. Anticancer Drugs. 22:949–962. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Maeda H: Nitroglycerin enhances vascular
blood flow and drug delivery in hypoxic tumor tissues: Analogy
between angina pectoris and solid tumors and enhancement of the EPR
effect. J Control Release. 142:296–298. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zeng X, Tao W, Mei L, Huang L, Tan C and
Feng SS: Cholic acid-functionalized nanoparticles of star-shaped
PLGA-vitamin E TPGS copolymer for docetaxel delivery to cervical
cancer. Biomaterials. 34:6058–6067. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Mayer B and Oberbauer R: Mitochondrial
regulation of apoptosis. News Physiol Sci. 18:89–94.
2003.PubMed/NCBI
|
|
27
|
Danial NN and Korsmeyer SJ: Cell death:
Critical control points. Cell. 116:205–219. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Suzuki Y, Nakabayashi Y, Nakata K, Reed JC
and Takahashi R: X-linked inhibitor of apoptosis protein (XIAP)
inhibits caspase-3 and -7 in distinct modes. J Biol Chem.
276:27058–27063. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kaul R, Mukherjee S, Ahmed F, Bhat MK,
Chhipa R, Galande S and Chattopadhyay S: Direct interaction with
and activation of p53 by SMAR1 retards cell-cycle progression at
G2/M phase and delays tumor growth in mice. Int J Cancer.
103:606–615. 2003. View Article : Google Scholar
|
|
30
|
Brake T and Lambert PF: Estrogen
contributes to the onset, persistence, and malignant progression of
cervical cancer in a human papillomavirus-transgenic mouse model.
Proc Natl Acad Sci USA. 102:2490–2495. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Smith JS, Green J, Berrington de Gonzalez
A, Appleby P, Peto J, Plummer M, Franceschi S and Beral V: Cervical
cancer and use of hormonal contraceptives: A systematic review.
Lancet. 361:1159–1167. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Sasieni P: Cervical cancer and hormonal
contraceptives: Collaborative reanalysis of individual data for 16
573 women with cervical cancer and 35 509 women without cervical
cancer from 24 epidemiological studies. Lancet. 370:1609–1621.
2007. View Article : Google Scholar
|
|
33
|
Gavrilescu MM, Todosi AM, Aniţei MG, Filip
B and Scripcariu V: Expression of bmi-1 protein in cervical, breast
and ovarian cancer. Rev Med Chir Soc Med Nat Iasi. 116:1112–1117.
2012.
|
|
34
|
McCredie MR, Sharples KJ, Paul C, Baranyai
J, Medley G, Jones RW and Skegg DC: Natural history of cervical
neoplasia and risk of invasive cancer in women with cervical
intraepithelial neoplasia 3: A retrospective cohort study. Lancet
Oncol. 9:425–434. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ikeda Y, Murakami A and Ohigashi H:
Ursolic acid: An anti- and pro-inflammatory triterpenoid. Mol Nutr
Food Res. 52:26–42. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Andersson D, Liu JJ, Nilsson A and Duan
RD: Ursolic acid inhibits proliferation and stimulates apoptosis in
HT29 cells following activation of alkaline sphingomyelinase.
Anticancer Res. 23:3317–3322. 2003.PubMed/NCBI
|
|
37
|
Ji HF, Li XJ and Zhang HY: Natural
products and drug discovery. Can thousands of years of ancient
medical knowledge lead us to new and powerful drug combinations in
the fight against cancer and dementia? EMBO Rep. 10:194–200. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Xavier CP, Lima CF, Preto A, Seruca R,
Fernandes-Ferreira M and Pereira-Wilson C: Luteolin, quercetin and
ursolic acid are potent inhibitors of proliferation and inducers of
apoptosis in both KRAS and BRAF mutated human colorectal cancer
cells. Cancer Lett. 281:162–170. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Hsu YL, Kuo PL and Lin CC: Proliferative
inhibition, cell-cycle dysregulation, and induction of apoptosis by
ursolic acid in human non-small cell lung cancer A549 cells. Life
Sci. 75:2303–2316. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Choi BM, Park R, Pae HO, Yoo JC, Kim YC,
Jun CD, Jung BH, Oh GS, So HS, Kim YM, et al: Cyclic adenosine
monophosphate inhibits ursolic acid-induced apoptosis via
activation of protein kinase A in human leukaemic HL-60 cells.
Pharmacol Toxicol. 86:53–58. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Cha HJ, Bae SK, Lee HY, Lee OH, Sato H,
Seiki M, Park BC and Kim KW: Anti-invasive activity of ursolic acid
correlates with the reduced expression of matrix
metalloproteinase-9 (MMP-9) in HT1080 human fibrosarcoma cells.
Cancer Res. 56:2281–2284. 1996.PubMed/NCBI
|
|
42
|
Liu L, Wu J, Zhang J, Li Z, Wang C, Chen
M, Wang Y, Sun Y, Wang L and Luo C: A compatibility assay of
ursolic acid and foodborne microbial exopolysaccharides by
antioxidant power and anti-proliferative properties in
hepatocarcinoma cells. J Food Agric Environ. 10:111–114. 2012.
|
|
43
|
Wang Y, Cui H, Li K, Sun C, Du W, Cui J,
Zhao X and Chen W: A magnetic nanoparticle-based multiple-gene
delivery system for transfection of porcine kidney cells. PLoS One.
9:e1028862014. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Delyagina E, Schade A, Scharfenberg D,
Skorska A, Lux C, Li W and Steinhoff G: Improved transfection in
human mesenchymal stem cells: Effective intracellular release of
pDNA by magnetic polyplexes. Nanomedicine (Lond). 9:999–1017. 2014.
View Article : Google Scholar
|
|
45
|
Wang Y, Cui H, Sun C, Du W, Cui J and Zhao
X: Study on performance of magnetic fluorescent nanoparticles as
gene carrier and location in pig kidney cells. Nanoscale Res Lett.
8:1272013. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Underbrink MP, Howie HL, Bedard KM, Koop
JI and Galloway DA: E6 proteins from multiple human
betapapillomavirus types degrade Bak and protect keratinocytes from
apoptosis after UVB irradiation. J Virol. 82:10408–10417. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Kabsch K and Alonso A: The human
papillomavirus type 16 E5 protein impairs TRAIL- and FasL-mediated
apoptosis in HaCaT cells by different mechanisms. J Virol.
76:12162–12172. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Wang X, Shi Q, Xu K, Gao C, Chen C, Li XL,
Wang GR, Tian C, Han J and Dong XP: Familial CJD associated PrP
mutants within transmembrane region induced Ctm-PrP retention in ER
and triggered apoptosis by ER stress in SH-SY5Y cells. PLoS One.
6:e146022011. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Xu K, Wang X, Shi Q, Chen C, Tian C, Li
XL, Zhou RM, Chu YL and Dong XP: Human prion protein mutants with
deleted and inserted octarepeats undergo different pathways to
trigger cell apoptosis. J Mol Neurosci. 43:225–234. 2011.
View Article : Google Scholar
|
|
50
|
Virkajärvi N, Pääkkö P and Soini Y:
Apoptotic index and apoptosis influencing proteins bcl-2, mcl-1,
bax and caspases 3, 6 and 8 in pancreatic carcinoma.
Histopathology. 33:432–439. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Sträter J, Herter I, Merkel G, Hinz U,
Weitz J and Möller P: Expression and prognostic significance of
APAF-1, caspase-8 and caspase-9 in stage II/III colon carcinoma:
Caspase-8 and caspase-9 is associated with poor prognosis. Int J
Cancer. 127:873–880. 2010.
|
|
52
|
Satoh K, Kaneko K, Hirota M, Toyota T and
Shimosegawa T: The pattern of CPP32/caspase-3 expression reflects
the biological behavior of the human pancreatic duct cell tumors.
Pancreas. 21:352–357. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Meggiato T, Calabrese F, De Cesare CM,
Baliello E, Valente M and Del Favero G: C-JUN and CPP32 (CASPASE 3)
in human pancreatic cancer: Relation to cell proliferation and
death. Pancreas. 26:65–70. 2003. View Article : Google Scholar
|
|
54
|
Noble P, Vyas M, Al-Attar A, Durrant S,
Scholefield J and Durrant L: High levels of cleaved caspase-3 in
colorectal tumour stroma predict good survival. Br J Cancer.
108:2097–2105. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Aylon Y and Oren M: p53: guardian of
ploidy. Mol Oncol. 5:315–323. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Murray-Zmijewski F, Slee EA and Lu X: A
complex barcode underlies the heterogeneous response of p53 to
stress. Nat Rev Mol Cell Biol. 9:702–712. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Blanchette P and Branton PE: Manipulation
of the ubiquitin-proteasome pathway by small DNA tumor viruses.
Virology. 384:317–323. 2009. View Article : Google Scholar
|
|
58
|
Cory S and Adams JM: The Bcl2 family:
Regulators of the cellular life-or-death switch. Nat Rev Cancer.
2:647–656. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
59
|
Youle RJ and Strasser A: The BCL-2 protein
family: Opposing activities that mediate cell death. Nat Rev Mol
Cell Biol. 9:47–59. 2008. View Article : Google Scholar
|
|
60
|
Zhang YX, Kong CZ, Wang HQ, Wang LH, Xu CL
and Sun YH: Phosphorylation of Bcl-2 and activation of caspase-3
via the c-Jun N-terminal kinase pathway in ursolic acid-induced
DU145 cells apoptosis. Biochimie. 91:1173–1179. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Wensveen FM, Alves NL, Derks IA, Reedquist
KA and Eldering E: Apoptosis induced by overall metabolic stress
converges on the Bcl-2 family proteins Noxa and Mcl-1. Apoptosis.
16:708–721. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Choi YH, Baek JH, Yoo MA, Chung HY, Kim ND
and Kim KW: Induction of apoptosis by ursolic acid through
activation of caspases and down-regulation of c-IAPs in human
prostate epithelial cells. Int J Oncol. 17:565–571. 2000.PubMed/NCBI
|
|
63
|
Dubrez-Daloz L, Dupoux A and Cartier J:
IAPs: More than just inhibitors of apoptosis proteins. Cell Cycle.
7:1036–1046. 2008. View Article : Google Scholar : PubMed/NCBI
|
